COMMUNIQUÉS West-GlobeNewswire

Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
01/09/2026
WATERTOWN, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
01/09/2026
TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic [...]
Telix Appoints David Gill as Chair
01/09/2026
David Gill appointed Chair of the Telix Board, effective immediately. Mr. Gill joined Telix as a Non-Executive Director in May 2026, with the intention that he would become Chair. Dr. Mark Nelson will continue to serve [...]
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
01/09/2026
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company [...]
Rutland Regional Medical Center Earns Four U.S. News & World Report High Performing Ratings
01/09/2026
Vermont hospital recognized for diabetes, hip replacement, knee replacement and hip fracture care in U.S. News’ 2026-2027 Best Hospitals procedure and condition ratings Rutland, VERMONT, Aug. 31, 2026 (GLOBE NEWSWIRE [...]
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
01/09/2026
An Important Step Forward for Access to LEQEMBI® for Eligible Patients in Canada TOKYO and CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that Canada’ [...]
Anteris to Present at September Healthcare Investor Conferences
31/08/2026
MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, [...]
L’été se termine, mais les situations d’urgence se poursuivent : la Croix-Rouge canadienne rappelle l’importance de se préparer
31/08/2026
Même si l’été tire à sa fin, les risques demeurent. Il est essentiel de se tenir informé et de rester vigilant. OTTAWA, Ontario, 31 août 2026 (GLOBE NEWSWIRE) -- La fréquence des catastrophes augmente au Canada. Il [...]
Summer is ending, emergencies aren’t: The Canadian Red Cross urges Canadians to prepare
31/08/2026
While summer may be winding down, the need to stay informed, vigilant, and prepared remains critical OTTAWA, Ontario, Aug. 31, 2026 (GLOBE NEWSWIRE) -- As disasters become more frequent across Canada, knowing how to [...]
BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
31/08/2026
- This voluntary agreement expands access for Medicaid patients to BridgeBio’s currently marketed medicine and lowers drug costs for Americans without jeopardizing innovation and sustainability in rare diseases - [...]
ArsenalBio Announces New Focus on In Vivo CAR T Programs to Leverage Investment in T cell Engineering
31/08/2026
Company to leverage its enabling technologies to expand into autoimmunity Strategic shift will align resources with the next phase of innovation in cell therapy Data from its clinical autologous cell therapy programs [...]
Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
31/08/2026
KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 [...]
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
31/08/2026
46% ORR observed among 76 evaluable patients in the ovarian cancer cohort with a median duration of response of 10.0 months Recent FDA interaction supports NDA submission strategy for accelerated approval of rezatapopt [...]
PMV Pharma Announces Proposed Public Offering of Securities
31/08/2026
PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule [...]
SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
31/08/2026
TEL AVIV, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
31/08/2026
Company reduces the maximum aggregate payments under its royalty financing agreement from $125 million to $65 million Company accelerated payment of $42.6 million upfront, bringing total payments made to date to $50 [...]
Health Catalyst to Participate in Upcoming Investor Conference
31/08/2026
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today [...]
Clover Health to Participate in Upcoming Investor Conferences
31/08/2026
WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: [...]
Inventiva nomme Chris Benecchi au poste de Chief Operating Officer
31/08/2026
Daix (France), New York City (New York, États-Unis), le 31 août, 2026 – Inventiva (Euronext Paris et Nasdaq : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique au stade clinique spécialisée dans le [...]

Pages